BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1692 related articles for article (PubMed ID: 19691201)

  • 1. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis.
    Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R
    Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
    Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City.
    Mannheimer SB; Sepkowitz KA; Stoeckle M; Friedman CR; Hafner A; Riley LW
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):319-25. PubMed ID: 9432387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia.
    Kimerling ME; Schuchter J; Chanthol E; Kunthy T; Stuer F; Glaziou P; Ee O
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):988-94. PubMed ID: 12475145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant tuberculosis in South African gold miners: incidence and associated factors.
    Churchyard GJ; Corbett EL; Kleinschmidt I; Mulder D; De Cock KM
    Int J Tuberc Lung Dis; 2000 May; 4(5):433-40. PubMed ID: 10815737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G; Carbonara S; Costa D; Gori A
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of drug-resistant tuberculosis: analysis of 11 countries.
    Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of drug resistance in Thai human immunodeficiency virus seropositive tuberculosis patients.
    Hongthiamthong P; Chuchottaworn C; Amatayakul N
    J Med Assoc Thai; 1994 Jul; 77(7):363-7. PubMed ID: 7876754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
    LoBue PA; Moser KS
    Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A; Elwood RK; Schulzer M; FitzGerald JM
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chapter 4: childhood contact screening and management.
    World Health Organization Stop TB Partnership Childhood TB Subgroup
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):12-5. PubMed ID: 17217124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thai drug-resistant tuberculosis predictive scores.
    Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
    Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.